These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25214056)

  • 21. The role of matrix metalloproteinases in the morphogenesis of the cerebellar cortex.
    Luo J
    Cerebellum; 2005; 4(4):239-45. PubMed ID: 16321879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinases as therapeutic targets for stroke.
    Yang Y; Rosenberg GA
    Brain Res; 2015 Oct; 1623():30-8. PubMed ID: 25916577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
    Janssens S; Lijnen HR
    Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial regulation of matrixmetalloproteinases and their inhibitors, fibrillar collagens and transforming growth factor-beta by Polypodium leucotomos, directly or in dermal fibroblasts, ultraviolet radiated fibroblasts, and melanoma cells.
    Philips N; Conte J; Chen YJ; Natrajan P; Taw M; Keller T; Givant J; Tuason M; Dulaj L; Leonardi D; Gonzalez S
    Arch Dermatol Res; 2009 Aug; 301(7):487-95. PubMed ID: 19373483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel strategies to delineate matrix metalloproteinase (MMP)-substrate relationships and identify targets to block MMP activity.
    Lindsey ML
    Mini Rev Med Chem; 2006 Nov; 6(11):1243-8. PubMed ID: 17100635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrodysplasia induced in dog skin by a matrix metalloproteinase (MMP) inhibitor--a mechanistic analysis.
    Tugwood JD; Kelsall J; Coverley LC; Westwood FR; Haque K; Huby RD
    Toxicol Sci; 2012 May; 127(1):236-45. PubMed ID: 22323515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular extracellular matrix in atherosclerosis.
    Chistiakov DA; Sobenin IA; Orekhov AN
    Cardiol Rev; 2013; 21(6):270-88. PubMed ID: 23422022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension.
    Lepetit H; Eddahibi S; Fadel E; Frisdal E; Munaut C; Noel A; Humbert M; Adnot S; D'Ortho MP; Lafuma C
    Eur Respir J; 2005 May; 25(5):834-42. PubMed ID: 15863640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent findings on scleral extracellular matrix and matrix metalloproteinases in the development of myopia].
    Long Q; Chu RY
    Zhonghua Yan Ke Za Zhi; 2005 Nov; 41(11):1047-9. PubMed ID: 16318765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac remodeling and failure From molecules to man (Part II).
    Fedak PW; Verma S; Weisel RD; Li RK
    Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases, and inflammation in cyclosporine A-induced gingival enlargement: a pilot in vitro study using a three-dimensional model of the human oral mucosa.
    Johanson M; Zhao XR; Huynh-Ba G; Villar CC
    J Periodontol; 2013 May; 84(5):634-40. PubMed ID: 22934840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinases in renal development.
    Haas CS; Gleason B; Lin S; Tramonti G; Kanwar YS
    Connect Tissue Res; 2004; 45(2):73-85. PubMed ID: 15763922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral thermal injury causes blood-brain barrier dysfunction and matrix metalloproteinase (MMP) expression in rat.
    Swann K; Berger J; Sprague SM; Wu Y; Lai Q; Jimenez DF; Barone CM; Ding Y
    Brain Res; 2007 Jan; 1129(1):26-33. PubMed ID: 17156757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinases in vascular physiology and disease.
    Siefert SA; Sarkar R
    Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications.
    Karthikeyan VJ; Lane DA; Beevers DG; Lip GY; Blann AD
    J Hum Hypertens; 2013 Feb; 27(2):72-8. PubMed ID: 22418748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function.
    Smith MF; McIntush EW; Ricke WA; Kojima FN; Smith GW
    J Reprod Fertil Suppl; 1999; 54():367-81. PubMed ID: 10692869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease.
    Ries C; Petrides PE
    Biol Chem Hoppe Seyler; 1995 Jun; 376(6):345-55. PubMed ID: 7576228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2001; 21(3B):2021-8. PubMed ID: 11497292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2000; 14(5):667-73. PubMed ID: 11212844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.